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Abstract
We present an optimized probe design for copy number variation (CNV) and SNP genotyping in the Plasmodium
falciparum genome. We demonstrate that variable length and isothermal probes are superior to static length
probes. We show that sample preparation and hybridization conditions mitigate the effects of host DNA
contamination in field samples. The microarray and workflow presented can be used to identify CNVs and SNPs
with 95% accuracy in a single hybridization, in field samples containing up to 92% human DNA contamination.
Background
Plasmodium falciparum is the intracellular parasite
r e s p o n s i b l ef o rt h em a j o r i t yo ft h ew o r l d ’s malaria mor-
bidity and mortality burden in humans, causing an esti-
mated 243 million episodes of malaria and 863,000
deaths each year [1]. Efforts to control and eradicate
malaria are hampered by the accelerated evolution of
drug resistance in the parasite. To date, the parasite has
developed resistance to all major antimalarial drugs,
raising concerns about the spread of drug-resistant para-
sites and the ability to effectively treat malaria [2]. The
development of new technologies aimed at understand-
ing parasite genome variability provides hope in identi-
fying new drug targets, implementing smarter treatment
plans, and ultimately reducing or eliminating the burden
of malaria.
Genome variation such as SNPs and copy number var-
iation (CNV) underpins P. falciparum drug resistance.
The primary determinant of chloroquine resistance is a
mutation in the P. falciparum chloroquine resistance
transporter gene on chromosome (chr) 7 [3,4]. In vitro
resistance to the antifolate drugs sulfadoxine and pyri-
methamine increases in a step-wise manner as mutations
accrue in dihydrofolate reductase and dihydropteroate
synthase [5-8]. Varying copy number of the P. falciparum
multidrug resistance 1 gene on chr 5 influences parasite
susceptibility to a range of antimalarial drugs, including
mefloquine, lumefantrine, quinine, and artemisinin
[9-11]. Amplification on chr 12 of GTP cyclohydrolase 1
of the folate biosynthesis pathway is correlated with anti-
folate drug resistance [12,13]. These examples emphasize
the importance of genomic variation in drug resistance
and need to assay both SNPs and CNV genome-wide in
the malaria parasite.
Microarrays provide a relatively fast and inexpensive
way of examining genomic variation in P. falciparum
[14]. Array comparative genomic hybridization (CGH)
has been successfully used to look at structural variation
and CNV in multiple P. falciparum strains [12,15-17],
while large-scale sequencing efforts identifying SNPs
[18-20] have spurred the development of SNP microar-
rays. Neafsey et al. [21] genotyped 1,638 out of 3,000
queried SNPs with 100% accuracy using an Affymextrix
3K SNP assay. Mu et al. [22] used Affymetrix molecular
inversion probe technology to genotype 2,763 of 3,354
SNPs with >90% call rate. Multiple groups have success-
fully applied CGH for SNP detection with 80 to 90%
sensitivity to approximately 3,000 SNPs [23,24] and
identified parameters influencing SNP detection [24,25].
However, the reported detection rates are based on a
core subset of SNPs (approximately 3,000) in a genome
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v5.5) [26].
Our central goal was to develop a single microarray
platform that can assay CNV and genotype SNPs simul-
taneously and to optimize this platform for the chal-
lenges of monitoring monoclonal patient blood samples
from field studies. We first empirically determined the
optimum probe lengths and melting temperatures for
SNP genotyping in the 81% AT P. falciparum genome.
This was used to guide the design of a single high-reso-
lution genotyping microarray with variable length probes
optimized for high quality SNP genotyping and CNV
detection (Figure 1). One half of the microarray interro-
gates 45,524 SNP loci using optimized resequencing
probes 29 to 41 bp in length capable of making a base
call at a precise nucleotide position [27]. The second
half identifies CNV using tiled CGH probes 50 to 75 bp
in length. We determine the reliability and accuracy of
t h eC N V - S N Pa r r a yu s i n gt h el a b o r a t o r yl i n e s3 D 7 ,
HB3, Dd2, SC05, and 7C126. We then validate the
utility and robustness of the microarray using field sam-
ples with limited parasite DNA and high human DNA
contamination present using blood collected from
humans at the Thailand-Burma border.
Results
Effects of probe length and probe melting temperature
on the robustness of base calls
Using a prototype 5K SNP chip, the performance of sta-
tic probe lengths was compared to the performance of
variable length, isothermal probes on base calling
robustness. A base call is considered robust when a
probe quartet has a single high nucleotide signal relative
to the other three nucleotide signals, and the sense and
antisense base calls are complementary. A Dscore calcu-
lating the background noise relative to the highest signal
i n t e n s i t yi nap r o b eq u a r t e t( F i g u r e1 ,g r e yi n s e t )w a s
used to compare the performance of static probes and
isothermal probes. A Dscore close to 1 indicates high
background noise and poor discrimination ability
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Figure 1 Microarray layout and design. The microarray contains blocks of probesets for SNP genotyping and CGH. SNP genotyping probesets
are composed of two probe quartets, one for each strand (red blowouts). Probes from one quartet typically have hybridization signals in a
similar dynamic range. These signals are used to determine a base call and calculate base calling robustness, which is expressed as a Dscore
where the two lesser hybridization signals are used to estimate background noise for each probe quartet (grey inset). The CGH probesets record
data that are used to generate log2 ratios of a test and reference sample.
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Page 2 of 10between probe signals, while a score close to 0 indicates
low background noise and good discrimination ability.
The mean Dscore of the 5K SNP chips was plotted for
static probe lengths (Figure 2a) and for probe melting
temperature (Figure 2b). Statistical analysis with a one-
way ANOVA indicates significant differences between
mean Dscore at various probe lengths (P < 0.0001), and a
Tukey’s multiple comparison test indicates that all
probe lengths except 39- and 41-mers have a signifi-
cantly different mean Dscore (P <0 . 0 5 ) .O u to ft h en i n e
tested probe lengths, 39-mer probes generated the low-
est mean Dscore with the best discrimination ability (¯ x =
0.3575). A one-way ANOVA analysis indicates probe
melting temperature Dscore are significantly different
from one another (P < 0.0001), and a Tukey’s multiple
comparison test indicates melting temperature in the
66°C range was significantly different from other melting
temperatures (P <0 . 0 5 ) .T h el o w e s tm e a nDscore with
the best discrimination ability for probe melting tem-
peratures was generated at 66°C from the range of 42 to
82°C (¯ x= 0.2647), and this outperformed any static
probe lengths. Similar performance was seen when com-
paring exons, introns, and intergenic regions (Figure S1
in Additional file 1).
Microarray base calling accuracy
Microarray data for 3D7, HB3, Dd2, SC05, and 7C126
(n = 15, 5, 3, 2, and 2, respectively) were compared to
genome sequence data to ascertain base calling accuracy
(Figure 3a). A useable base call was made at a SNP
locus when the sense and antisense probesets indicated
complementary bases; otherwise, there would be no
base call for that SNP locus. Figure 3a depicts mean
microarray accuracy plotted by Dscore;a l s od e p i c t e da r e
CNV-SNP array data for the SNP subsets that are
represented on SNP genotyping microarrays developed
b yt h eB r o a dI n s t i t u t e[ 2 1 ]a n dN I H[ 2 2 ] .T h eC N V -
SNP array genotypes 1,507 of the 1,631 publicly avail-
able Broad Institute SNPs and 2,621 of the 2,743 pub-
licly available NIH SNPs. For all SNP sets, a lower
Dscore is associated with higher accuracy. SNPs from the
Broad Institute and NIH maintain >95% accuracy at all
Dscore cutoffs with 97.1% accuracy and 98.7% accuracy,
respectively, at a Dscore cutoff of 1. The accuracy of all
SNPs assayed on the CNV-SNP array maintain >95%
accuracy for Dscore ≤0.9 but drops to an average accu-
racy of 94.6% at a Dscore of 1. Figure 3b depicts the
mean number of base calls made by the microarray
plotted by Dscore for all SNPs and for the SNP subsets
from the Broad Institute and NIH microarray platforms
(Figure 3b). On average, a microarray hybridization
yielded 36,948 base calls from the 45,524 assayed SNP
loci for a base call rate of 81.2%. The Broad Institute
and NIH SNP subsets had an average call rate of 90.7%
and 93.0%, respectively. Lower numbers of base calls
a r em a d ea tm o r es t r i n g e n tDscore cutoffs for all data
sets. When comparing accuracy for SNP subsets in
exons, introns, and intergenic regions, introns and inter-
genic regions perform similarly, and exons exhibited the
best performance (Table 1).
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Figure 2 Base calling robustness is affected by probe length and melting temperature. Mean Dscore is plotted by (a) probe length and (b)
probe melting temperature where vertical lines indicate 95% confidence intervals. Lower discrimination scores indicate greater base calling
robustness. Fixed length 39-mers provided the best performance for any static probe length tested. Probes with a 66°C melting temperature
provided the best performance for any melting temperature range and surpassed the performance of 39-mer probes.
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Segmentation analyses on multiple hybridizations of
HB3 and Dd2 against the reference 3D7 detected the
same copy number events detected in HB3 and Dd2
hybridizations against 3D7 found previously [25]. Med-
ian probe spacing between the 5’ end of CGH probes is
52 bp, providing a fine resolution view of CNV that can
precisely implicate breakpoints to within 100 bp. The
resolution provided by this platform is equivalent to a
previous NimbleGen CGH chip [25]. Figure 4 shows
CGH scatterplots demonstrating microarray-based CNV
breakpoint detection in comparison with the exact
breakpoint determined through capillary sequencing.
CNV events are highly reproducible between replicate
hybridizations with this microarray platform (Figure S2
in Additional file 1). Features, including a 500 bp CNV
event, were recognized and consistent between hybridi-
zations; however, it becomes more difficult to confi-
dently detect small CNV events algorithmically. CNV
event detection is still possible with whole genome
amplification (WGA) samples (Figure S3 in Additional
file 1), although the amplification process introduces
noise, confounding CNV detection by any platform, par-
ticularly reducing confidence in small events. Degraded
samples can not be recovered for effective CGH by
WGA.
Applications to P. falciparum field samples
Standard probe labeling protocols utilize random non-
amers with balanced base composition. However, P.
falciparum has an extremely high AT content of 81%
[28], which reduces the performance of 50% AT ran-
dom nonamers and may introduce bias during amplifi-
cation of the parasite genome. To test the effect of
random nonamer AT composition on labeling perfor-
mance and microarray data, labeling yields of 65% AT
random nonamers (38,357 ± 3468.1 ng) were com-
pared with labeling yields of 50% AT random nona-
mers (18,865 ± 4530.7 ng). The data pass a
D’Agostino-Pearson normality test and a paired t-test,
indicating that 65% AT random nonamers generate a
significantly greater yield of labeled DNA than 50% AT
random nonamers (P < 0.01). We see no adverse
effects on base calling accuracy or CGH performance
when using this modified labeling procedure.
Larger yields of labeled DNA are generated by 65%
AT random nonamers, allowing the amount of initial
starting DNA to be reduced. We evaluated decreasing
amounts of starting material that could generate the
necessary 10 μg of labeled DNA for hybridization.
Labeling yields using 250 ng, 375 ng, 500 ng, and 1,000
ng of starting DNA for 3D7, HB3, and Dd2 were
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Figure 3 Microarray accuracy rate and base calling. (a) Microarray base calling accuracy rate was calculated by comparing microarray base
calls with sequence data for five parasite genomes. At more stringent discrimination scores, accuracy rate increased. SNP subsets demonstrate
greater performance than average if those SNPs are more amenable to hybridization-based interrogation (NIH and Broad subsets). (b) Mean
number of base calls produced at various Dscore cutoffs for all SNP loci and for SNP subsets from previously published microarray platforms (NIH
and Broad).
Table 1 Microarray accuracy in exons, introns, and
intergenic regions
Location Accuracy, Dscore ≤1.0 Accuracy, Dscore ≤0.5
Exon 96.3% 98.5%
Intron 91.2% 95.4%
Intergenic region 90.4% 94.9%
Tan et al. Genome Biology 2011, 12:R35
http://genomebiology.com/2011/12/4/R35
Page 4 of 10quantified (Figure 5a) and hybridized on the microarray.
More than 10 μg of labeled DNA was obtained from all
labeling reactions and no base calling or CNV detection
differences were seen between the different starting
amounts, indicating a starting DNA amount ≤250 ng is
sufficient to generate high quality hybridization data.
Human DNA is invariably present in field-collected
samples of parasite DNA and is especially high when
leukocyte depletion is not used in the extraction
method. In some cases, human DNA may constitute
>90% of the total DNA extracted from infected blood
samples and can hinder downstream uses of the parasite
DNA for microarray hybridizations or sequencing.
Nucleic acid blockers are commonly used in microarray
hybridizations to prevent random probe binding to non-
target nucleic acids and were tested on our microarray
to prevent performance reduction in samples with sig-
nificant amounts of human DNA contamination. We
tested various nucleic acid blockers and found that 1×
Denhardt’s solution provided the greatest number of
base calls with no negative impact on CGH data when
compared to hybridizations with bovine serum albumin,
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Figure 4 CNV breakpoint detection with CGH. CGH data for a CNV on chr 5 in the Dd2 genome accurately detects the breakpoints for the
(a) beginning and (b) end of the event within hundreds of base pairs. The vertical red lines indicate the breakpoint locations as previously
determined through sequence data [43]. Nt, nucleotides.
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Figure 5 Field sample analysis with the CNV-SNP array. (a) The manufacturer-recommended starting amount is 1,000 ng of DNA to produce
at least 10 μg of labeled product. However, 250 ng of parasite DNA consistently produced sufficient labeled product when using 65% AT
nonamers. Error bars indicate one standard deviation. (b) Hybridizations with field samples - straight from patient blood, or whole genome
amplified - produced microarray data on par with standard lab clones, even when significant human DNA contamination was present.
Microarray accuracy was determined through Illumina sequencing of lab-adapted parasites. Patient blood samples were hybridized with the
addition of 1× Denhardt’s solution while WGA samples were not.
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and yeast tRNA. To test for the effect of human DNA
contamination on our microarray, several DNA samples
were extracted from Thailand-Burma patient blood sam-
ples or were whole genome amplified from patient
blood. The amount of human DNA present in each
sample was quantified, and 33 to 92% of the total DNA
was found to be human, with WGA samples containing
the most human DNA. WGA is generally, but not
always, helpful as there is some variability in data gener-
ated from WGA samples. Using 250 ng of parasite
DNA, field samples were hybridized to the microarray
and examined for the number and accuracy of base calls
(Figure 5b); accuracy was determined using Illumina
sequences generated from the same samples (M Man-
ske, unpublished observations). This platform is able to
produce high quality data with samples containing
extensive host DNA contamination equivalent to data
from purified lab line DNA (Figure 5b).
Discussion
T h eC N V - S N Pa r r a yp r o v i d e sr o b u s t ,a c c u r a t ed a t af o r
both laboratory- and field-derived samples. Through
optimizations described here, the CNV-SNP array over-
comes many hurdles associated with molecular work on
P. falciparum field samples. Lower starting amounts of
DNA are possible when using 65% AT random nona-
mers that compensate for the extreme AT bias of the
genome. This optimization is especially useful for field
sample DNA, which is typically scarce and difficult to
obtain. It also eliminates the need for in vitro culture
adaptation of field samples, which is typically used to
generate enough DNA for applications like next-genera-
tion sequencing and is known to alter CNV and skew
results of CNV analyses [29,30]. Using our modified
protocol, the CNV-SNP array requires no more than
250 ng of starting parasite DNA with no compromise in
data quality. Moreover, the ample yields of labeled DNA
from 250 ng of starting parasite DNA indicate that the
lower limit has not yet been defined, raising the possibi-
lity that finger prick blood samples on filter paper are
accessible to this technology. In addition, the CNV-SNP
array is robust to samples with high host DNA contami-
nation (>90%) with no drop in data quality, making
microarray-based genotyping complementary to higher
resolution next-generation sequencing that is sensitive
to human DNA contamination in field samples, often
requiring sample preprocessing for target DNA enrich-
ment. Notably, high human DNA contamination and
low amounts of parasite DNA present serious challenges
to genotyping the large number of samples necessary for
genome-wide association studies.
Probe design optimizations contribute to the perfor-
mance of this microarray for the P. falciparum genome.
Sense and antisense resequencing probe quartets were
used for SNP genotyping on the CNV-SNP array. A
SNP call required that sense and antisense probe quar-
tets made complementary calls; furthermore, the robust-
ness of the base call was evaluated using the ratio of
background signal versus the probe with the greatest
signal intensity. Signal intensities within SNP probe
quartets were more similar to each other than to probes
in other probe quartets or between sense and antisense
probe quartets of the same locus (Figure 1) and indi-
cates the importance of measuring the background sig-
nal for each individual SNP quartet - as provided by the
resequencing probesets - rather than background noise
from the entire array or locus.
Resequencing probes were optimized for SNP geno-
typing in P. falciparum by comparing the performance
of probes at static lengths with probes balanced by melt-
ing temperature on a prototype 5K SNP array. Probe
melting temperature outperformed static probe lengths
for optimal SNP detection at a probe melting tempera-
ture of 66°C with performance that was reasonably con-
sistent in exons, introns, and intergenic regions (Figure
S1 in Additional file 1).
Our results on optimal probe length and melting tem-
perature differ from findings in another study [31]. This
is likely due to the use of different methods for calculat-
ing probe melting temperature and our optimization to
the AT-rich P. falciparum genome. However, our
broader conclusion that variable length or isothermal
probes provide optimal SNP detection is supported
across various organisms [31,32], and indicate that
longer, isothermal probes increase signal strength while
also being short enough to remain sensitive to single
base mismatches [32-35].
Resequencing probesets designed for a 66°C melting
temperature were generated for 45,524 SNP loci for
inclusion on the CNV-SNP array. While longer, isother-
mal probes improve SNP genotyping, certain loci are
more easily genotyped than others, and some remain
inaccessible to microarrays and short-read next-genera-
tion sequencing technologies. For instance, SNPs in
exons have greater genotyping success than SNPs in
introns or intergenic regions, likely due to regions of
high AT richness or interspersed sequence repetitiveness
that hinder probe design and binding specificity in
intronic and intergenic regions. Current SNP genotyping
microarrays, such as those developed by the NIH and
the Broad Institute [21,22], are focused on high quality
SNP loci that are easily genotyped across microarray
platforms (Figure 3). However, the use of isothermal
probes designed at an optimal melting temperature
allows us to interrogate more difficult loci and maximize
the overall number of SNPs that can be robustly geno-
typed on the CNV-SNP array (on average, 36,948
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hybridization).
An interesting debate surrounds the continued value
of microarrays with the emergence of next-generation
sequencing. As the cost of next-generation sequencing
continues to decrease and protocols continue to
improve, we will see a realization of the platform pro-
viding ultimate resolution and throughput, provoking
the prediction that microarrays will soon be rendered
obsolete. However, we suggest that the CNV-SNP array
will continue to be useful as an ‘everylab’ tool alongside
next-generation sequencing. Whole genome sequencing
underpins the SNP discovery needed for chip design; in
general, whole genome architecture and ultra-resolution
mapping require fully sequenced and assembled gen-
omes. The customizable microarray platform continues
to improve in density (4.2 million element custom
designs are anticipated in 2011) and offers unique con-
figurations up to 12-plex of 135K probes, leading to a
scenario in which a global set of SNPs identified by
sequencing can be precisely represented on microarrays
for regionally focused or hypothesis-driven designs. To
date, microarrays remain cheaper, produce data more
quickly, require less computational innovation, and are
especially useful for processing large numbers of sam-
ples, while producing sufficient resolution and quality
for genome-wide association studies and population
genomic analysis. Furthermore, although progress is
being made in scoring CNV using next-generation
sequencing, that technology still lags behind the perfor-
mance of microarray CGH.
Conclusions
As P. falciparum continues to evolve and evade control
and eradication efforts, high-throughput, cost-effective
methods of monitoring genomic variation are critical to
understanding parasite adaptation. The high AT content
of the P. falciparum genome is technically challenging
for most molecular methods; however, the flexibility of
the microarray platform described here allows users to
customize and optimize microarrays to individual gen-
omes through alterations of probe lengths, types, and
numbers and adjustment of hybridization strategy. This
process is applicable to population genomic studies in a
wide range of organisms. Utilizing this flexibility, we
created a custom high-density CNV-SNP array contain-
ing both resequencing probes capable of SNP genotyp-
ing and CGH probes for CNV detection. The CNV-SNP
array is a reliable, accurate platform that allows simulta-
neous investigation of CNV and SNPs in a single hybri-
dization. Its low cost, quick turn-around time, low DNA
requirements, and resilience to human DNA contamina-
tion make it a valuable tool for population genomic
studies.
Materials and methods
Microarray design
Probe length optimization
As an initial step in SNP genotyping optimization, a
NimbleGen resequencing microarray consisting of vari-
able length resequencing probesets was developed to
assay 5,347 SNP loci. A NimbleGen resequencing probe-
set is composed of eight probes per SNP locus: four
probes each for interrogation of sense and antisense
strands. Each probe quartet is identical except for the
central nucleotide that assays the nucleotide variant
[27]. We downloaded 101,581 candidate SNP loci from
PlasmoDB v5.5 [26] for parasite isolates HB3, Dd2, V1/
S, 7G8, D10, FCC-2, K1, RO-33, D6, GHANA1, FCB,
and IT. Common SNPs (SNPs identified in at least two
parasite isolates) were blasted against the 3D7 genome
to verify a unique 21-mer SNP typing probe sequence.
Probesets with more than one exact match in the gen-
ome were discarded. Of the remaining candidate probe-
sets, 5,347 SNP loci were randomly chosen for inclusion
on the 5K SNP chip at nine different probe lengths: 21,
25, 29, 33, 35, 37, 39, 41, and 45-mers. Hybridizations
following NimbleGen standard CGH procedures [36]
were performed using DNA from laboratory clones 3D7,
HB3, Dd2, 7G8, and D10.
CNV-SNP array
Using NimbleGen’s 3-plex custom chip layout, each
plex in our 3-plex 720K NimbleGen microarray con-
tains resequencing probes for SNP genotyping and
CGH probes for CNV detection (Figure 1). Probes
were synthesized using maskless photolithography
[37,38] with CGH probes attached by 5T linkers and
resequencing probes attached with 15T linkers. Of the
101,581 candidate SNP loci downloaded from Plas-
moDB and BLASTed for uniqueness, probesets for all
SNPs reported in at least two parasites lines were
included in the microarray. Some SNPs represented by
as i n g l ei s o l a t ew e r ei n c l u d e do nt h ea r r a ya n dp r i o r i -
tized by mutation types sensitive to array detection
[25]. In total, 45,524 SNP loci queried by 364,192
probes balanced to 66°C melting temperature were
included on the microarray. CGH microarray probes
were designed using standard NimbleGen CGH proto-
col [36] modified for the P. falciparum genome.
Briefly, probes were tiled through the genome at 4-bp
interval spacing and filtered for 60 to 80°C melting
temperature and 50 to 75 bp length. The resulting
probes were clustered with nearest neighbors and
sorted to remove probes with extensive sequence iden-
tity to any other probe. Probes with more than one
50-mer exact match in the genome or located in
hypervariable var/rif/stevor genes were discarded. The
median spacing between the start of the 355,803 CGH
probes is 52 bp.
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F r e s hc u l t u r e so fc l o n e d3 D 7 ,H B 3 ,D d 2 ,S C 0 5 ,a n d
7C126 lines derived from genotype-confirmed stock
material were grown under standard cultivation condi-
tions [39,40]. Parasite DNA was extracted using stan-
dard phenol/chloroform extraction and concentrated by
salt precipitation [39]. Parasite DNA from the Thailand-
Burma border was collected from 5 ml whole blood of
symptomatic patients visiting malaria clinics. Buffy coats
from the blood samples were removed and infected red
blood cells cultured for 24 h to allow ring stage para-
s i t e st om a t u r et os c h i z o n t st op r o v i d em o r eD N A .
DNA was extracted using a standard phenol/chloroform
protocol. Parasite isolates were screened for multiple
infections and identical clones using seven polymorphic
microsatellite markers: ARA2 (chr 11), POLYa (chr 4),
TA1 (chr 6), C2M1 (chr 2), C3M54 (chr 3), TA60 (chr
13), and C4M30 (chr 4). These markers were amplified
using fluorescent end-labeled oligos and run on an ABI
3100 capillary sequencer (Applied Biosystems Inc., Fos-
ter City, CA, USA) and alleles scored using GeneScan
(Applied Biosystems Inc.) and Genotyper (Applied Bio-
systems Inc.) software. Samples were considered multi-
ple clone infections if one or more of the seven
microsatellite loci showed multiple alleles. Only unique
genotypes were included in the study. Thailand-Burma
samples with an inadequate amount of DNA were
whole genome amplified using phi29 DNA polymerase
(Fidelity Systems, Gaithersburg, MD, USA). WGA sam-
ples were cleaned using a standard phenol/chloroform
protocol. Parasite DNA concentrations in the Thailand-
Burma samples were measured using quantitative PCR.
Patient samples were amplified using SYBRgreen
(Applied Biosystems Inc.) with primers specific to the P.
falciparum ama1 gene. Reactions were run on an ABI
PRISM 7900HT realtime PCR machine and DNA
amounts calculated by comparison with a dilution series
of pure DNA from parasite line 3D7. DNA from lab-
adapted samples was submitted to the Wellcome Trust
Sanger Institute (Hinxton, UK) for Illumina sequencing
using 76-bp paired-end reads.
Microarray hybridizations
Labeling and hybridization were conducted using stan-
dard NimbleGen CGH procedures [36]. gDNA (250 ng
to 1 μg) was denatured at 98°C for 10 minutes in the
presence of 1 OD of cy3 or cy5-labeled random nona-
mers at 50% AT richness or 65% AT richness (TriLink
Biotechnologies, San Diego, CA, USA). The denatured
sample was quick chilled on ice and incubated with 50
units of Klenow fragment (New England Biolabs, Ips-
wich, MA, USA) and dNTP mix (6 mM each in TE
(Sigma Aldrich, St Louis, MO, USA)) for 2 h at 37°C.
Reactions were terminated with 0.5 M EDTA and
precipitated with 5 M NaCl in isopropanol. Labeled pro-
duct was resuspended in water, and 10 μgo ft e s ta n d
reference samples combined (6 μgf o r5 KS N Pc h i p
samples), dried down, and resuspended in hybridization
buffer (Roche NimbleGen, Inc., Madison, WI, USA);
hybridizations for patient blood samples included 1×
Denhardt’s solution (Sigma Aldrich) in the hybridization
buffer. The combined sample was denatured at 95°C for
5 minutes and allowed to hybridize on the array for 24
h (16 h for 5K SNP chip samples) at 42°C in a Nimble-
Gen hybridization system (Roche NimbleGen, Inc.).
Microarrays were washed sequentially in Wash Buffer I
(2 minutes at room temperature), Wash Buffer II (1
minutes at room temperature), and Wash Buffer III (15
s at room temperature; Roche NimbleGen, Inc.) and
dried for 1 minuets in a Microarray High-Speed Centri-
fuge (Arrayit Corp., Sunnyvale, CA, USA). CNV-SNP
arrays were scanned at 2 μm resolution using a Nimble-
Gen MS 200 Microarray Scanner (Roche NimbleGen,
Inc.). 5K SNP chips were scanned at 5 μmr e s o l u t i o n
using a GenePix Pro 4200A Scanner (Molecular Devices,
Inc., Sunnyvale, CA, USA). Microarray data are depos-
ited at Gene Expression Omnibus, accession number
[GEO:GSE28287].
Microarray data analysis
SNP analysis
Data for 3D7, HB3, Dd2, SC05, and 7C126 were
extracted from scanned images and resequencing base
reports generated using NimbleScan v2.5 (Roche Nim-
bleGen, Inc.). Base calls were made on resequencing
probesets when the sense and antisense probes made
complementary base calls. The discrimination score
(Dscore) for each probe quartet was calculated as a back-
ground corrected ratio of the signal from the second
greatest intensity probe from a probe quartet divided by
the greatest intensity probe using custom perl scripts
(Figure 1, grey insert): (Second highest signal intensity -
Background)/(Highest signal intensity - Background).
Background for each probe quartet was calculated as the
average of the third and fourth highest signal intensities
[32]. There is some noise inherent in this base calling
method, which can be mitigated by performing technical
replicates or incorporating probe replicates into the chip
design. For SNP genotyping probes, probeset melting
temperature was calculated as previously described [36]
where mean melting temperature was calculated from
all probes in each probe quartet. The accuracy of the
base calls made by the resequencing probes was calcu-
lated as the percentage of base calls that matched the
reference genome for 3D7 or draft genome assemblies
for HB3, Dd2, SC05, and 7C126 [20,28,41]. To ascertain
the base called at a SNP locus in the genome assembly,
resequencing probes were mapped to draft genome
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probe length with less than four mismatched/indel posi-
tions excluding the central nucleotide. Illumina
sequence data were aligned to the 3D7 reference gen-
ome with SNP-o-matic software [42] to identify SNP
locations for comparison to microarray data.
Copy number variation analysis
Data for HB3 and Dd2 (n = 6 and n = 4, respectively)
hybridized against 3D7 were extracted from scanned
images and normalized using NimbleScan v2.5 (Roche
NimbleGen, Inc.). Copy number events from the seg-
mentation analysis in HB3 and Dd2 against the refer-
ence 3D7 were compared to known CNV in the
published literature [25].
Additional material
Additional file 1: Supplementary Figures S1 to S3. Figure S1: pptimal
probe melting temperature is consistent in exons, introns, and intergenic
regions. Mean Dscore is plotted by probe melting temperature in exons,
introns, and intergenic regions; vertical lines indicate 95% confidence
intervals. Probes with approximately 66°C melting temperature
consistently provided the best performance. Figure S2: CGH data
reproducibility. CGH scatterplots for individual CNV events are displayed
for replicate hybridizations from independent labeling reactions
demonstrating data reproducibility. CNV events from three separate
parasite clones are displayed: (a) Dd2; (b) HB3; (c) SC05. The CNV
breakpoints are precisely identified between hybridizations. Figure S3:
CNV detection in a WGA field sample. CGH scatterplot for a CNV event
detected in a WGA field sample, M1064. Four genes (PFE1150w,
PFE1155c, PFE1160w, and PFE1165c) are affected by this CNV, including
the P. falciparum multidrug resistance gene, pfmdr1.
Abbreviations
Bp: base pair; CGH: comparative genomic hybridization; chr: chromosome;
CNV: copy number variation; SNP: single nucleotide polymorphism; WGA:
whole genome amplification.
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